<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Oswalt CJ</submitter><funding>NCI NIH HHS</funding><pagination>284-290</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9172893</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>45(6)</volume><pubmed_abstract>The mechanisms underlying tumor immunosurveillance and their association with the immune-related adverse events (irAEs) associated with checkpoint inhibitor immunotherapies remain poorly understood. We describe a metastatic melanoma patient exhibiting multiple episodes of spontaneous disease regression followed by the development of several irAEs during the course of anti-programmed cell death protein 1 antibody immunotherapy. Whole-exome next-generation sequencing studies revealed this patient to harbor a pyrin inflammasome variant previously described to be associated with an atypical presentation of familial Mediterranean fever. This work highlights a potential role for inflammasomes in the regulation of tumor immunosurveillance and the pathogenesis of irAEs.</pubmed_abstract><journal>Journal of immunotherapy (Hagerstown, Md. : 1997)</journal><pubmed_title>Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events.</pubmed_title><pmcid>PMC9172893</pmcid><funding_grant_id>R37 CA249085</funding_grant_id><funding_grant_id>R01 CA251136</funding_grant_id><pubmed_authors>Haykal T</pubmed_authors><pubmed_authors>DeVito NC</pubmed_authors><pubmed_authors>Ko DC</pubmed_authors><pubmed_authors>Oswalt CJ</pubmed_authors><pubmed_authors>Al-Rohil RN</pubmed_authors><pubmed_authors>Theivanthiran B</pubmed_authors><pubmed_authors>Hanks BA</pubmed_authors><pubmed_authors>Holtzhausen A</pubmed_authors><pubmed_authors>Salama AKS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events.</name><description>The mechanisms underlying tumor immunosurveillance and their association with the immune-related adverse events (irAEs) associated with checkpoint inhibitor immunotherapies remain poorly understood. We describe a metastatic melanoma patient exhibiting multiple episodes of spontaneous disease regression followed by the development of several irAEs during the course of anti-programmed cell death protein 1 antibody immunotherapy. Whole-exome next-generation sequencing studies revealed this patient to harbor a pyrin inflammasome variant previously described to be associated with an atypical presentation of familial Mediterranean fever. This work highlights a potential role for inflammasomes in the regulation of tumor immunosurveillance and the pathogenesis of irAEs.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul-Aug 01</publication><modification>2024-11-12T21:23:05.521Z</modification><creation>2024-11-12T21:23:05.521Z</creation></dates><accession>S-EPMC9172893</accession><cross_references><pubmed>35621992</pubmed><doi>10.1097/CJI.0000000000000425</doi></cross_references></HashMap>